Back to Market返回行情

EHC Encompass Health Corporation

USHealthcare
$111.02+0.70%ClosedMarket Cap: $11.01B

As of 2026-07-09 16:00

Why EHC matters now

Encompass Health Corporation (EHC) is a US stock in Healthcare. The latest InvestLog snapshot shows $111.02 with +0.70% on the session and $11.01B in market capitalization; recent performance reads 1-month -6.42% and YTD -7.64%.

The latest financial table shown here is Q1 2026, with revenue of $1.59B, net income of $194.5M, and EPS of $1.93. Investors can compare that operating picture with valuation signals such as P/E 19.06 and FCF yield 4.8%.

The latest indexable market news headline is "Here's Why Encompass Health (EHC) is a Strong Value Stock" from Zacks Investment Research.

Additional event context on this page matters because analyst consensus is Buy with a median target of $146.00; recent insider activity includes COLTHARP DOUGLAS E filing M-Exempt. These signals are research inputs, not a recommendation.

Valuation

P/E (TTM)

19.06

PEG

0.79

P/B

3.86

P/S

1.60

EV/EBITDA

8.45

DCF Value

$36.61

FCF Yield

4.8%

Div Yield

0.8%

Margins & Returns

Gross Margin

58.8%

Operating Margin

17.9%

Net Margin

10.0%

ROE

25.3%

ROA

8.3%

ROIC

13.3%

Financials

PeriodRevenueNet IncomeEPS
Q1 2026$1.59B$194.5M$1.93
Q4 2025$1.54B$146.1M$1.43
FY 2025$5.94B$566.2M$5.54
Q3 2025$1.48B$126.5M$1.24

Analyst Ratings

Consensus

Buy

Target (Consensus)

$146.00

Target (Median)

$146.00

Target Range

$140.00 - $152.00

Strong Buy: 1Buy: 12Hold: 0Sell: 0Strong Sell: 0
BarclaysOverweight
2026-05-05
BarclaysOverweight
2026-02-06
BarclaysOverweight
2025-10-30
UBSBuy
2025-10-02
KeybancOverweight
2025-09-16

Trading Activity

Insider Trades

COLTHARP DOUGLAS Eofficer: EVP & Chief Financial Officer
Sell2026-05-18
COLTHARP DOUGLAS Eofficer: EVP & Chief Financial Officer
Sell2026-05-18
COLTHARP DOUGLAS Eofficer: EVP & Chief Financial Officer
Sell2026-05-18
COLTHARP DOUGLAS Eofficer: EVP & Chief Financial Officer
Sell2026-05-18
Tuer Patrick Williamofficer: EVP, Chief Operating Officer
Sell2026-05-12

Company Info

Sector

Healthcare

Industry

Medical - Care Facilities

Country

US

Exchange

Beta

0.59

Encompass Health Corporation delivers a range of post-acute healthcare services across the United States, offered both in dedicated facilities and directly within patients' homes. The company's operations are divided into two primary divisions: Inpatient Rehabilitation, and Home Health and Hospice. Its Inpatient Rehabilitation division specializes in providing focused recovery treatment, available on an inpatient or outpatient basis. This care is designed for individuals recuperating from significant health challenges such as strokes, neurological disorders, cardiac and pulmonary issues, brain and spinal cord injuries, complex orthopedic conditions, and amputations. The Home Health and Hospice segment primarily serves the Southeast and Texas regions. Within this segment, home health services encompass a variety of Medicare-certified care options for adult patients, including skilled nursing, medical social work, home health aide assistance, and various therapies like physical, occupational, and speech therapy. Hospice services, on the other hand, provide in-home comfort and support for terminally ill patients and their families. As of June 1, 2022, Encompass Health maintained a substantial network, managing 149 hospitals, 252 home health locations, and 99 hospice locations spread across 42 U.S. states and Puerto Rico. The company, which established its roots in 1983 and is headquartered in Birmingham, Alabama, was formerly known as HealthSouth Corporation until its name change to Encompass Health Corporation in January 2018.